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Introduction
Injury to the CNS unleashes a complex series of molecular events 
underlying both acute and sustained death of neural tissue. Induc-
tion of cell death in the CNS triggers a cascade of continuous (sec-
ondary) neurodegeneration, resulting in a substantially higher 
degree of tissue loss than could have been predicted from the 
severity of the initial damage (1). While the role of T cells in mediat-
ing autoimmune neuroinflammation has been studied intensively 
(2–7), their role in neurodegeneration and neuroprotection is still a 
matter of debate. T cell inflammation associated with CNS injury 
was largely viewed as detrimental (8, 9). However, over a decade 
ago, T cells were shown to play a protective role after injury (10), 
challenging the prevailing dogma. Furthermore, based on exoge-
nous administration of autoimmune T cells, it was suggested that 
the cells mediating such neuroprotection are self reactive (11–13). 
However, other reports indicated that autoreactive T cells may 
also be implicated in continuous neurodegeneration after injury 
(14), leaving open questions, i.e., what makes a T cell protective or 
pathogenic, what is the antigenic specificity of T cells that respond 
to injury spontaneously, and what is their mechanism of function 
in benefitting the injured CNS.
Here, we used two in vivo CNS injury models (optic nerve 
crush injury and spinal cord contusive injury) to address the 
impact of T cells both on neuronal survival (after optic nerve crush) 
and neurological recovery (after spinal cord injury). We show the 
unexpected observation that neuroprotection mediated by T cells 
in response to CNS injury does not require MHCII–T cell recep-
tor (MHCII-TCR) interaction and, instead, damage-associated 
molecular mediators from the injured CNS skew T cells toward 
IL-4 production in a MyD88-dependent manner. To uncover the 
underlying molecular mechanisms of this neuroprotective effect, 
we used in vitro systems to demonstrate that T cell–derived IL-4 
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CNS injury. We used a well-established and highly reproduc-
ible mouse model of acute optic nerve crush injury to quantita-
tively determine the effects on survival of the parent cell bodies 
of optic nerve axons, i.e., the retinal ganglion cells (RGCs) at 1 
week after injury (Figure 1A). As expected from previous stud-
ies with different T cell–deficient animals (17), MHCII KO mice 
that are missing CD4+ T cells (Figure 1B) exhibited reduced neu-
ronal survival compared with that of background-matched wild-
type mice (Figure 1C; contralateral retinas with uninjured optic 
nerves did not differ in RGC counts, Figure 1D).
To determine whether the lack of CD4+ T cells also affects 
functional recovery from CNS injury, we used a calibrated spinal 
cord contusion injury at the T9-T10 vertebra and measured hind 
limb functional recovery with the Basso mouse scale (18). In line 
with the optic nerve injury experiments, MHCII KO mice displayed 
worse functional recovery compared with that of their wild-type 
counterparts (Figure 1E). These results suggest that endogenous 
conventional CD4+ T cells are indeed vital for immune-mediated 
neuroprotection and recovery after CNS injury.
To address our question of whether antigen recognition by 
T cells is essential to their neuroprotective response, we trans-
ferred CD4+ T cells from naive C57BL/6 mice into MHCII KO mice. 
This transferred CD4+ population is unable to be maintained in 
the periphery due to the lack of MHCII in these mice; however, in 
line with previous reports (19), the cells survived for a week in the 
recipient mice (Figure 2, A and B). Surprisingly, mice that received 
CD4+ T cells displayed significantly more surviving neurons after 
optic nerve crush injury than vehicle-treated MHCII KO mice lack-
ing CD4+ T cells (Figure 2C; RGC counts in contralateral retinas 
potentiates neurotrophin signaling on injured neurons through 
neuronal IL-4 receptors and, thus, directly promotes neuronal sur-
vival and sprouting. These results alter the view of antigen speci-
ficity in the injury-induced T cell response and provide a role for 
injured tissue–derived molecular mediators in shaping the neuro-
protective adaptive immune response.
Results
The accumulation of T cells in the injured CNS has been previ-
ously shown (15), although what leads to T cell activation and 
the requirement for MHCII-TCR interaction for their neuropro-
tective phenotype are not well understood. Since autoimmune 
T cells can be destructive, such as in autoimmune diseases, 
we hypothesized that there may be an alternative protective 
signaling pathway in CD4+ T cells that would lead to a neuro-
protective response to injury. To distinguish between antigen- 
specific and “alternative” activation of T cells after CNS injury, 
we first used major histocompatibility class II (MHCII) knockout 
mice (H2-Ab1–/–H2-Aa–/–H2-Eb1–/–H2-Eb2–/–H2-Ea–/– mice; herein 
referred to as MHCII KO mice). 
Since MHCII is required for CD4+ T cell development, 
activation, and long-term survival, these mice do not contain 
conventional CD4+ T cells but only a small population of CD4+ 
T cells with limited TCR diversity that recognize antigen in an 
antibody-like fashion (16); in contrast, their CD8+ T cell and 
B cell repertoires are normal (Supplemental Figure 1; supple-
mental material available online with this article; doi:10.1172/
JCI76210DS1). Prior to readministration of T cells into MHCII 
KO mice, we examined their baseline spontaneous response to 
Figure 1. MHCII KO mice without CD4+ T cells display poor outcomes after CNS injury. (A) Representative images from wild-type or MHCII KO retinas 
labeled with the retrograde tracer Fluoro-Gold. Images are from retinas 7 days after injury. Scale bar: 500 μm (retina whole mount); 100 μm (individual 
field). (B) Representative flow cytometry plots of CD4+ and CD8+ lymphocytes in the deep cervical lymph nodes of C57BL/6 or MHCII KO mice. (C) RGC 
survival after optic nerve crush injury in MHCII KO or wild-type mice assessed 7 days after injury by Fluoro-Gold staining (n = 8, wild-type; n = 11, MHCII KO; 
representative of 2 experiments). (D) RGC counts (mean ± SEM) in the contralateral retinas of MHCII KO or wild-type mice (n = 3, wild-type; n = 3, MHCII 
KO, representative of 2 experiments). (E) Locomotor scores of C57BL/6 or MHCII KO mice after a 70-kDy impact below the T9-T10 vertebra was assessed by 
a blinded observer using the Basso mouse scale (n = 7, C57BL/6; n = 8, MHCII KO; representative of 2 experiments). (C and D) **P < 0.01, 2-tailed Student’s 
t test. (E) **P < 0.01, repeated-measure 2-way ANOVA with Bonferroni’s post-test. Error bars represent SEM.
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unable to interact with endogenous antigen-presenting cells due 
to the MHCII deficiency in the host and, thus, they were not able 
to respond to antigenic stimuli. MHCII KO recipients of MHCII 
KO thymi were unable to generate mature T cells and served as 
negative control. Once the mice had developed CD4+ T cells, they 
underwent optic nerve injury. Mice that received wild-type thymi, 
and thus developed CD4+ T cells, displayed significantly more sur-
viving neurons than the recipients of MHCII KO thymi that did not 
possess CD4+ T cells (Figure 2F; RGC counts in contralateral ret-
inas did not differ between the groups, Supplemental Figure 2B). 
These results further suggest that mature CD4+ T cells can exert a 
beneficial effect after sterile injury, even in the absence of recogni-
tion of their cognate antigen.
As an alternate method of studying the role of antigen-non-
specific T cells in CNS injury, we also examined neuronal survival 
in TCR transgenic mice bearing only ovalbumin-specific CD4+ 
T cells on a Rag1–/– background (OT-II/Rag1–/– mice). These 
OT-II/Rag1–/– mice, which lack the entire adaptive immune system 
except for a population of CD4+ T cells specific for ovalbumin (Fig-
ure 2G), exhibited an enhanced neuroprotective response after 
did not differ between the groups, Supplemental Figure 2A). To 
determine whether antigen specificity is also dispensable for CD4+ 
T cell–mediated functional recovery from spinal cord injury, we 
transferred MHCII KO mice with CD4+ T cells from naive C57BL/6 
mice or vehicle at both 1 day after spinal cord contusive injury and 
8 days after spinal cord injury. As with optic nerve injury, mice that 
received CD4+ T cells exhibited greater functional recovery from spi-
nal cord injury than mice that were treated with saline (Figure 2D).
To confirm that the phenotype that we observed was not due 
to activation of CD4+ T cells in their naive host or due to adoptive 
transfer, we repeated the study using a model in which CD4+ T cells 
were allowed to develop in vivo in MHCII KO mice. To this end, we 
transplanted P2 thymi from wild-type or MHCII KO donors under 
the kidney capsules of 3-week-old MHCII KO recipients. These 
exogenous thymi were implanted 6 weeks before optic nerve injury 
to allow enough time for sufficient production of CD4+ T cells. In 
agreement with the previously published works (20), introduction 
of the wild-type thymi allowed the MHCII KO recipients to gen-
erate endogenous CD4+ T cells (Figure 2E). Although wild-type 
thymi-transplanted mice now had mature T cells, these cells were 
Figure 2. Antigen specificity is not required for CD4+ T cell–mediated neuroprotection. (A) Representative flow cytometry plots and (B) quantification 
of the deep cervical lymph nodes of control or CD4+ T cell–injected MHCII KO mice (n = 5, MHCII KO; n = 6, MHCII KO + CD4+ T cells; representative of 2 
experiments). (C) RGC survival after optic nerve crush injury in MHCII KO mice injected with vehicle or CD4+ T cells on the day of injury (n = 5, MHCII KO; 
n = 6, MHCII KO + CD4+ T cells; representative of 2 experiments). (D) Locomotor score of MHCII KO mice injected with vehicle or CD4+ T cells (n = 4 mice 
per group; representative of 2 experiments). (E) Representative flow cytometry plots of CD4+ and CD8+ lymphocytes in the deep cervical lymph nodes of 
MHCII KO mice implanted with either MHCII KO or wild-type thymi. (F) RGC survival of MHCII KO mice implanted with either MHCII KO or wild-type thymi 
(n = 5, wild-type thymus; n = 8 MHCII KO thymus; representative of 2 experiments). (G) Representative flow cytometry plots of CD4+ lymphocytes in the 
deep cervical lymph nodes of Rag1–/– or OTII/Rag1–/– mice. (H) RGC survival of Rag1–/– and OTII/Rag1–/– mice assessed 7 days after injury (n = 6, Rag1–/–;  
n = 10, OTII/Rag1–/–; representative of 3 experiments). (B, C, F, and H) *P < 0.05, **P < 0.01, ***P < 0.001, 2-tailed Student’s t test. (D) *P < 0.05, 
repeated- measure 2-way ANOVA. Error bars represent SEM.
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viously in the healthy (21) and injured (25) CNS, it was reason-
able to assume that it could be acting as a T cell–derived neu-
roprotective molecule. To address the role of IL-4 on neuronal 
survival after CNS injury, we used again the optic nerve crush 
injury model to compare neuronal survival between Il4–/– mice 
and background-matched wild-type controls. Il4–/– mice exhib-
ited impaired neuronal survival as compared with that of their 
wild-type counterparts (Figure 4A; RGC counts in contralateral 
retinas did not differ between the groups, Supplemental Figure 
2D). Importantly, CD4+ T cell infiltration into the injured tis-
sue was not affected in Il4–/– mice (Figure 4B). To test whether 
the protective IL-4 is indeed produced by the immune cells, 
we transplanted Il4–/– or wild-type bone marrow into irradi-
ation-conditioned wild-type hosts. After the bone marrow 
had fully engrafted (peripheral engraftment at >90%), mice 
underwent optic nerve injury. Recipients of Il4–/– bone marrow 
demonstrated impaired neuronal survival as compared with that 
of control mice that received wild-type bone marrow (Figure 
4C; RGC counts in contralateral retinas did not differ between 
the groups, Supplemental Figure 2E). To further ensure that the 
neuroprotective IL-4 originated from CD4+ T cells, we injected 
acutely isolated IL-4–deficient CD4+ T cells (from Il4–/– donors) 
or IL-4–sufficient CD4+ T cells (from wild-type donors on the 
same genetic background) into Rag1–/– (T cell–deficient) mice 
and subjected these mice to optic nerve crush injury 3 weeks 
later. Wild-type CD4+ T cells led to a higher neuronal survival 
in Rag1–/– hosts than Il4–/– T cells (Figure 4D; RGC counts in con-
optic nerve crush compared with that of Rag1–/– background con-
trols (Figure 2H; RGC counts in contralateral retinas did not differ 
between the groups, Supplemental Figure 2C), further indicating 
that cognate antigen recognition is not prerequisite for T cells to 
acquire their neuroprotective properties after CNS injury.
In search for a better understanding of molecular mechanism 
underlying T cell–mediated neuroprotection and recovery, we ana-
lyzed the cytokines that T cells from the injured spinal cord produced 
and found that one of the major cytokines produced by T cells at the 
site of injury was IL-4. Interestingly, we found more IL-4–producing 
T cells at the site of injury than in the lymph nodes or even in the 
meninges (Figure 3, A and B), a compartment that is known for its 
IL-4–skewed environment (21, 22). T cells from the injury site were 
the major source for IL-4 production, as compared with any other 
cells in the injured CNS (Figure 3C). To further confirm that IL-4 
production in the spinal cord is due to CD4+ T cells, we examined 
cultured CD4+ T cells, microglia, astrocytes, and neurons for IL-4 
expression. While Th0 cells in vitro expressed abundant Il4 mRNA 
and this expression was further increased by culturing the cells in 
Th2-skewing conditions, there was a lack of Il4 expression by resident 
nonimmune CNS cells, i.e., astrocytes, neurons, and oligodendro-
cytes (Figure 3D). Although these cells were tested in the culture con-
ditions and could potentially upregulate IL-4 after injury, the results 
in Figure 3C suggest that injury does not induce IL-4 in neural cells.
Due to shared signaling pathways used by both IL-4 and 
growth factors, such as neurotrophins and IGF1 (through IRS1/2 
signaling; refs. 23, 24), and since IL-4 has been implicated pre-
Figure 3. CD4+ T cells produce IL-4 in 
the CNS after injury. (A) Representative 
histograms and (B) quantification of IL-4–
expressing CD4+ T cells from the lymph 
nodes, meninges, and spinal cords of 
C57BL/6 mice after contusion injury (n = 4 
per group; representative of 3 experiments). 
(C) Representative histograms showing 
IL-4 expression in CD4+ T cells, CD45hiCD11b+ 
macrophages, CD45loCD11b+ microglia, or 
CD45– resident CNS cells in the spinal cords 
of C57BL/6 mice after contusion injury. 
Gray histograms indicate flow minus one 
(FMO) controls. (D) Il4 mRNA expression 
of cultured cells, normalized to expression 
of Gapdh (n = 4 per group; representative 
of 2 experiments). *P < 0.05, ***P < 0.001, 
1-way ANOVA with Bonferroni’s post-test. 
Error bars represent SEM.
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we postulated that soluble factors from the injured CNS induce 
a Th2 phenotype directly on T cells. To assess Th2 skewing in 
wild-type T cells, we measured a master transcriptional regula-
tor of Th2 cells, Gata3 (26), by real-time quantitative PCR. Iso-
lated CD4+ lymphocytes were incubated with CD4– antigen-pre-
senting cells and injured optic nerves for 3 days, after which an 
increase in Gata3 in CD4+ T cells was evident (Figure 5A), sug-
gesting a Th2 skew by factors within the CNS tissue. Although 
Gata3 is a master regulator of Th2 skew, we also assessed more 
direct measurements of IL-4 in these cells. Since IL-4 is a diffi-
cult cytokine to measure and due to its 2-step production pro-
cess (27), protein levels of IL-4 are the only reliable measure. To 
this end, we first used T cells from reporter KN2 mice. KN2 is 
a reporter mouse line, which expresses human CD2, indicating 
IL-4 protein translation (27). Incubation of KN2-derived T cells 
with injured CNS tissue indeed showed an increase in T cell–
derived IL-4 production (Figure 5, B and C). Additionally, flow 
cytometric analysis of intracellular staining for IL-4 in cultured 
T cells (directly assessing IL-4 production) also demonstrated 
an increase in IL-4 production upon incubation with optic 
nerves (Figure 5, D and E), suggesting that the optic nerve tissue 
is sufficient to drive a Th2 response in CD4+ T cells.
Since we detected a correlation between IL-4 expression by 
T cells and their Gata3 expression and due to a robustness of 
Gata3 assessment by qPCR, we proceeded with our studies to 
tralateral retinas did not differ between the groups, Supplemen-
tal Figure 2F), suggesting that the primary source of neuropro-
tective IL-4 after injury is indeed the CD4+ T cells.
To determine whether the neuroprotective effect of IL-4 
would also affect functional recovery, we performed spinal cord 
injury on Il4–/– mice and wild-type controls. As expected from the 
optic nerve injury model, Il4–/– mice displayed a deficit in func-
tional recovery from spinal cord injury (Figure 4E). Additionally, 
we transferred wild-type or Il4–/– CD4+ T cells into Rag1–/– mice. 
The T cells were allowed to engraft in the recipients for 3 weeks 
before we performed spinal cord injury. Rag1–/– mice that received 
wild-type T cells exhibited enhanced functional recovery from spi-
nal cord injury compared with those mice that received Il4–/– CD4+ 
T cells, confirming that a neuroprotective CD4+ T cell response is 
IL-4 mediated (Figure 4F).
Two mechanistic questions remained unanswered: what 
induces T cells at the site of injury to express IL-4 and how does 
IL-4 mediate neuroprotection and recovery?
To address the mechanism underlying the Th2 skew at the 
site of injury, we established an in vitro system in which CD4+ 
lymphocytes from cervical lymph nodes were incubated with 
isolated optic nerves (in the presence of the CD4– fraction from 
the lymph node serving as antigen-presenting cells). Because our 
findings indicated that the induction of a neuroprotective T cell 
response does not require MHCII-TCR interactions (Figure 1), 
Figure 4. IL-4–producing CD4+ T cells mediate neuroprotection after CNS injury. (A) Scatter plots represent RGC survival of Il4–/– or wild-type mice (n = 10,  
wild-type; n = 7, Il4–/–; representative of 2 experiments). (B) Scatter plots represent the number of CD4+ T cells that infiltrated into the CNS parenchyma 
of Il4–/– or wild-type mice (n = 8 per group; representative of 2 experiments). (C) RGC survival of wild-type → wild-type or Il4–/– → wild-type bone marrow 
chimeras assessed 7 days after injury (n = 7, wild-type bone marrow; n = 6, Il4–/– bone marrow; representative of 2 experiments). (D) RGC survival of Rag1–/– 
mice injected with either wild-type or Il4–/– CD4+ T cells. RGC survival was quantified 7 days after injury (n = 13 wild-type and Il4–/– T cell injected; represen-
tative of 2 experiments). (E) Locomotor score of wild-type and Il4–/– mice that have undergone a spinal cord injury (n = 6, wild-type; n = 10, Il4–/–; represen-
tative of 2 experiments). (F) Locomotor score of Rag1–/– mice reconstituted with either wild-type or Il4–/– CD4+ T cells from naive mice that have undergone 
a spinal cord injury (n = 4 per group; representative of 2 experiments). (A–D) *P < 0.05, 2-tailed Student’s t test. (E and F) *P < 0.05, repeated-measure 
2-way ANOVA with Bonferroni’s post-test. Error bars represent SEM.
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identify the “factor” that leads to IL-4 production using Gata3 as 
an expression readout. Of note, optic nerves isolated from 3-day 
optic nerve–injured or naive mice resulted in similar degrees of 
Gata3 induction in T cells (Figure 5F), suggesting that the fac-
tor(s) is produced acutely after injury caused by excision of the 
optic nerves. To determine whether additional “damage” to 
the nerve is necessary to promote this phenotype or whether 
removal from the mouse causes sufficient damage to drive the 
Th2 response, we cultured nerves that had been minced or left 
intact and found that the damage to the axons from removal 
of the nerves from their hosts was sufficient to drive the Gata3 
induction in CD4+ T cells (Figure 5G).
As we did not see a requirement for antigen specificity of CD4+ 
T cells in order for them to become protective in vivo, we asked 
whether antigen specificity played a role in this Th2 skew in vitro. 
Therefore, we first cultured T cells with myelin, which contains 
many of the antigens that have been implicated in T cell autoim-
munity to the CNS. However, purified myelin did not have any 
effect on Gata3 expression in CD4+ T cells (Figure 5H).
Since in vivo MHCII recognition was not needed for the 
T cell–mediated beneficial response, we replaced the wild-type 
antigen-presenting cells (CD4– fraction) with MHCII KO anti-
gen-presenting cells in our cultures of wild-type T cells to deter-
mine whether MHCII signaling on antigen-presenting cells was 
necessary for the induction of Th2 skewing by CNS tissue. Indeed, 
MHCII deficiency on antigen-presenting cells did not affect Gata3 
induction in CD4+ T cells in response to incubation with the injured 
optic nerve (Figure 6A). Similarly, T cells derived from OTII/Rag1–/– 
mice and, therefore, not responding to any of the antigens pres-
ent in the injured tissue also demonstrated upregulation of Gata3 
Figure 5. CNS tissue skews T cells toward a Th2 phenotype. (A) CD4+ T cells from total lymph nodes were incubated with optic nerves and antigen- 
presenting cells. After culture, CD4+ T cells were resorted and Gata3 expression analyzed using qRT-PCR (relative to Gapdh) (n = 3 per group; representative 
of >3 experiments). (B) Representative flow cytometry plots and (C) quantification of human CD2 (hCD2) expression (reporter for IL-4 protein; KN2 mice) in 
cultures of lymph node cells incubated with or without optic nerves (n = 3, control; n = 7, optic nerve; representative of 2 experiments). (D) Representative 
flow cytometry plots and (E) quantification of IL-4+CD4+ T cells in cultures of lymph node cells incubated with or without optic nerves, as a percentage of 
CD4+ T cells (n = 4, control; n = 4, optic nerve; representative of 3 experiments). (F) Gata3 expression in sorted CD4+ T cells after culture in the presence 
of optic nerves isolated from either injured or naive mice (n = 4 per group; representative of 2 experiments). (G) Gata3 expression in the presence of optic 
nerves that had been minced or left intact (n = 3 per group; representative of 2 experiments). (H) CD4+ T cells from deep cervical lymph nodes and anti-
gen-presenting cells were incubated in the presence or absence of 80 μg of myelin vesicles before CD4+ T cells were resorted and assayed for Gata3 relative 
to Gapdh (n = 5 per condition; representative of 2 experiments). (A, C, E, and H) *P < 0.05, **P < 0.01, 2-tailed Student’s t test. (F and G) **P < 0.01,  
***P < 0.001, 1-way ANOVA with Bonferroni’s post-test. Error bars represent SEM.
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after incubation with the injured optic nerves (Figure 6B). More-
over, removal of antigen-presenting cells from the cultures of 
T cells with the optic nerves did not affect the induction of Gata3 in 
T cells (Figure 6C), suggesting that the factor originating from the 
injured CNS interacts directly with T cells and skews them to the 
Th2 lineage. To determine whether there was a cellular interaction 
that was causing this upregulation of Gata3 or whether there was 
a soluble factor that was mediating the effects of optic nerves on 
T cells, we cultured CD4+ T cells with optic nerves that were sep-
arated from the T cells by 0.4-μm Transwell. Optic nerves were 
able to upregulate Gata3 mRNA in CD4+ T cells, even through 
Transwell separation (Figure 6D), suggesting that soluble factors 
originating in the injured CNS were responsible for this effect. To 
confirm this phenotype, we conditioned media with optic nerve 
explants for 3 days. The media was then added to T cell cultures 
after being passed through a 0.22-μm filter. As expected, condi-
tioned media was also able to induce the upregulation of Gata3 in 
T cells (Figure 6E). To rule out the possibility that the optic nerves 
could be producing IL-4 themselves to mediate this effect, we 
used optic nerves from Il4–/– mice, and a similar degree of Gata3 
induction was achieved (Figure 6F).
We hypothesized that the Th2 skewing is induced via molec-
ular patterns/mediators or “alarmins” (28) originating from 
the damaged tissue. Pattern recognition is mediated by unique 
receptors, such as TLRs, among other pattern recognition recep-
tors, which are highly expressed on immune cells (29). Many 
TLRs signal through a common signaling molecule, MyD88, 
which mediates downstream transcriptional activation by several 
mechanisms (30). To address a possible role of MyD88 signaling 
in CNS-induced Th2 skewing, we used T cells from wild-type or 
Myd88–/– mice incubated with the optic nerves. Whereas T cells 
from wild-type mice demonstrated, as expected, upregulation 
of Gata3, no such upregulation was detected in the cultures with 
Myd88–/– T cells (Figure 7A), suggesting that the signaling pathway 
that results in Th2 skewing is mediated, at least in part, via MyD88 
intrinsic to T cells.
To determine whether the myriad of molecular “alarmins” 
that are released and signal from the injured CNS induce a desired 
neuroprotective T cell response in vivo, we isolated T cells from 
the injured spinal cords of wild-type and Myd88–/– mice and looked 
at intracellular cytokine expression. While there was high expres-
sion of IL-4 in wild-type T cells, Myd88–/– mice exhibited lower 
amounts of IL-4 (Figure 7, B and C). Of note, IL-4 expression was 
not completely eliminated in Myd88–/– mice, suggesting that other 
MyD88-independent pathways may play a role in the induction 
of IL-4 expression after spinal cord injury. To examine whether 
MyD88 signaling is physiologically relevant to a neuroprotective 
immune response after injury, we examined optic nerve injury in 
Myd88–/– mice and found that their neuronal survival was indeed 
significantly impaired compared with that of control mice (on iden-
tical genetic background with sufficient MyD88 expression) (Figure 
7D; RGC counts in contralateral retinas did not differ between the 
Figure 6. CNS tissue does not mediate the 
effects on CD4+ T cells through antigen or 
IL-4. (A) Gata3 expression in sorted wild-
type CD4+ T cells cocultured with MHCII KO 
antigen-presenting cells in the presence 
or absence of optic nerves from uninjured 
mice (n = 3 per group; representative of 
2 experiments). (B) Gata3 expression in 
sorted OTII/Rag1–/– CD4+ T cells cocultured 
with wild-type antigen-presenting cells in 
the presence or absence of optic nerves 
from uninjured mice (n = 9 wild-type; n = 5 
OTII/Rag1–/–; representative of 2 experi-
ments). (C) Gata3 expression in sorted wild-
type CD4+ T cell cultures lacking antigen-pre-
senting cells incubated in the presence or 
absence of optic nerves from uninjured 
mice (n = 3 per group; representative of >3 
experiments). (D) Gata3 expression in sorted 
CD4+ T cells after culture in the presence 
or absence of isolated optic nerves placed 
in a Transwell with 0.4-μm pores (n = 3 per 
group; representative of 2 experiments). (E) 
Gata3 expression in sorted CD4+ T cells after 
culture in optic nerve–conditioned media or 
control media (n = 5 per group; representa-
tive of 2 experiments). (F) Gata3 expres-
sion (mean ± SEM) in sorted CD4+ T cells 
after culture in the presence or absence of 
isolated optic nerves from Il4–/– mice (n = 4 
per group; representative of 2 experiments). 
*P < 0.05; **P < 0.01; ***P < 0.001, 2-tailed 
Student’s t test used for statistical analysis. 
Error bars represent SEM.
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independent stimulation protocol (concanavalin [ConA] 
activation) and kept in a collagen matrix next to the 
slice increased axonal outgrowth in this ex vivo model, 
whereas Th1 cells failed to do so (Figure 8B). In order 
to define the impact of IL-4 on axons, induction of out-
growth by Th2 cells served as a readout assay for our 
further analyses. In fact, axonal outgrowth achieved 
by Th2 cells was inhibited by the addition of an IL-4–
neutralizing antibody (Figure 8C) but remained unaf-
fected by neutralization of either IL-10 or IL-13 (Figure 
8D), strongly suggesting that IL-4 is a key Th2-derived 
molecule that mediates the effect. To ensure that this 
response was specific to IL-4 signaling on the EC slices, we exam-
ined Th2 cells cocultured with EC slices from Il4r–/– mice. In con-
trast to control EC slices, Th2-skewed cells were not able to induce 
axonal outgrowth in slices from Il4r–/– mice (Figure 8E).
To further demonstrate that IL-4–induced outgrowth after 
lesion in the ex vivo model results in sprouting into the proper 
target tissue, we cultured EC slices from β-actin-EGFP mice with 
wild-type hippocampal slices (33) to determine whether applica-
tion of recombinant IL-4 would increase the regrowth of axons 
from the EC through their physiological route, the perforant path, 
into the hippocampus (Figure 8F). Indeed, exogenous IL-4 was 
able to potentiate axonal ingrowth (EGFP+ axons) into the hippo-
campus (Figure 8G).
To determine whether IL-4 could be signaling directly to 
neurons, we first examined whether neurons express the correct 
receptor for binding IL-4. In cultured neurons, IL-4Rα can be 
found as mRNA and protein (Figure 8, H and I). We next exam-
ined whether IL-4 could directly signal to neurons to promote axon 
elongation using cultures of cortical neurons that were treated with 
IL-4. Indeed, treatment of neuronal cultures with IL-4 promoted 
enhanced elongation of axons when compared with cultures 
treated with vehicle (Supplemental Figure 4), suggesting that IL-4 
signaling directly to neurons could be promoting this Th2-driven 
axonal outgrowth seen in our slice cultures. To test this hypothesis, 
we cultured Th2 cells with wild-type or Camk2g-Cre Il4rfl/fl slices (in 
which only neurons are deficient in IL-4R, while other neural cells 
in the slices are expressing their regular levels of IL-4R). Whereas 
slices from wild-type mice showed, as expected, axonal outgrowth 
in response to Th2 (but not Th1) cells, slices from Camk2g-Cre Il4rfl/fl 
mice showed no such response to Th2 cells (Figure 8J), indicating 
that IL-4 signals directly through neuronal IL-4R.
groups, Supplemental Figure 2G). Bone marrow transplantation 
from Myd88–/– or wild-type donors into irradiation-conditioned 
wild-type recipients recapitulated the results obtained with germ-
line knockout mice (Figure 7E; RGC counts in contralateral retinas 
did not differ between the groups, Supplemental Figure 2H), fur-
ther pointing to the importance of the immune cells as responders 
to MyD88-dependent signals.
To determine what factor(s) might be playing a role in inducing 
Th2 skewing after CNS injury, we tested a panel of MyD88-depen-
dant TLR ligands. Much to our surprise, none of the tested TLR lig-
ands increased Gata3 in T cells, and several decreased its expression 
instead (Supplemental Figure 3). The IL-1 family of cytokines (IL-1α, 
IL-1β, IL-18, and IL-33) all signal in an MyD88-dependent manner 
(31) and may mediate the effect either collectively or synergistically. 
Future studies should focus on addressing the role of these cyto kines 
as well as looking for additional players in the injured CNS that may 
lead to induction of neuroprotective IL-4–producing T cells.
Importantly, to address the molecular mechanism of IL-4– 
mediated beneficial affect on injured neurons, we used a well- 
established and robust ex vivo axonal outgrowth model using cor-
tical explant cultures (ECs), allowing for the analysis of soluble 
factors on outgrowth in an organotypic setting (ref. 32 and Figure 
8A). This model, while not an in vivo system, better mimics the 
in vivo condition than isolated neuronal cultures, which lack the 
glial compartment that plays an important role in proper axonal 
outgrowth. Furthermore, the physiological connections of the 
entorhinal cortex, which have already been established in vivo by 
the time of tissue excision (postnatal day 2–3), need to be severed 
in order to produce the ECs, and thus the outgrowth is a response 
of the damaged neurons attempting to reconnect to their phys-
iologic target. IL-4–producing Th2 cells obtained by an antigen- 
Figure 7. MyD88-dependent Th2 skewing. (A) Gata3 expression 
in sorted wild-type or Myd88–/– CD4+ T cells cultured with optic 
nerves from uninjured mice (n = 3 per group; representative of 2 
experiments). (B) Representative histograms and (C) quantitation 
of IL-4 expression in CD4+ T cells from the spinal cords of C57BL/6 
and Myd88–/– mice after contusion injury (representative of 2 
experiments). (D) RGC survival of wild-type and Myd88–/– mice 7 
days after optic nerve injury (n = 18, wild-type; n = 17, Myd88–/–; 
representative of 2 experiments). (E) RGC survival of wild-type → 
wild-type or Myd88–/– → wild-type bone marrow chimeras 7 days 
after injury (n = 6, wild-type bone marrow recipients; n = 7, Myd88–/– 
bone marrow recipients; representative of 2 experiments). (A)  
***P < 0.001, 1-way ANOVA with Bonferroni’s post-test. (C–E)  
*P < 0.05, 2-tailed Student’s t test. Error bars represent SEM.
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promote recovery after CNS injury directly via neuronal IL-4 
receptors, potentiating neurotrophin signaling to promote neu-
ronal survival and regrowth (Figure 10).
Due to the potency of autoimmune T cells to promote neu-
roprotection (10), it has been assumed that the T cells that medi-
ate neuroprotection after CNS injury need to be specific to CNS 
antigens. However, we show here that T cell–dependent neuro-
protection does not necessarily require antigen recognition and 
neuroprotective T cell phenotype could be induced independently 
of MHCII. Although T cell specificity may be required for T cell 
migration to the injured tissue (37), our results demonstrate that, 
once at the site of injury, a neuroprotective Th2 skew can occur 
independent of antigen recognition.
Furthermore, our results do not exclude the possibility that 
CNS self-antigen–specific T cells exert a more potent neuroprotec-
tion than that of antigen nonspecific cells or that the endogenous 
CD4+ T cells that mediate neuroprotection in wild-type mice can 
be boosted by vaccination with CNS self antigen, as has been pre-
viously reported (13). Boost of CNS-reactive T cells may allow a 
higher amount of infiltration into the injured CNS, which can then 
be skewed by the injured tissue into a neuroprotective IL-4–pro-
ducing phenotype and hence a higher degree of neuroprotection 
and recovery (38).
The results presented here suggest a mechanistic explana-
tion to the phenomenon of T cell–mediated neuroprotection and 
recovery after CNS trauma. A better understanding of the actions 
of T cells after injury may have far-reaching clinical implications 
for the design of new treatment modalities for axonal damage in 
the course of CNS injuries, a progressive form of multiple sclero-
sis, and other neurodegenerative disorders by targeting the pro-
tective antigen-independent IL-4–producing T cells, while pre-
venting destructive autoimmunity that commonly occurs with a 
CNS antigen-specific T cell response.
The T cell response to damage-associated molecules originat-
ing from the injured CNS is MyD88 dependent, although Myd88 
knockout mice still show IL-4 production by T cells (albeit to a 
lesser extent). This suggests that additional pathways may be 
involved through which T cells respond to damage signals follow-
ing injury. None of the tested TLR agonists were able to induce 
Gata3 expression in T cells. Since it is reasonable to hypothe-
size that several molecules originating from the injured CNS 
may influence T cells to induce a compensatory response in the 
CNS, future studies should concentrate on molecules such as the 
members of IL-1 cytokine family (IL-1α, IL-1β, IL-18, and IL-33), 
which exert their effects through MyD88 independently of TLRs. 
Importantly, the fact that neuroprotective T cells are induced in an 
MHCII-independent manner contrasts with a previous hypothesis 
that neuroprotective T cells need to be specific to brain antigens, 
i.e., autoimmune (10), and suggests that safe therapies targeting 
T cells may be developed in the future that avoid the risk of auto-
immune disease development.
What makes the search for neuroprotective therapies after 
CNS injury especially pressing is that there currently are no neuro-
protective treatments that have undergone rigorous testing in the 
clinical setting. While several small phase I trials held promise for 
treatments, such as hyperbaric oxygen treatment, progesterone 
treatment, and hypothermia, these treatments either have not yet 
As mentioned above, IL-4 can act via a signaling pathway 
shared with growth factors, including neurotrophins, through 
the IRS family of adaptor proteins (23, 24), which influences sig-
nal transduction through AKT and MAPK signaling. Interest-
ingly, a previous study showed no indications for a relevant role 
of endogenous neurotrophins in the initiation of axon outgrowth 
from cortical explants. However, application of recombinant NT-3 
potentiated this spontaneous outgrowth (33), pointing to a role of 
neurotrophins in strengthening the signaling in the preactivated 
axonal growth pathway. To determine whether this potentiation 
of neurotrophin signaling is involved in IL-4–mediated axonal 
outgrowth, we tested axonal outgrowth induced by Th2 cells after 
blocking the neurotrophin signaling. Indeed, we found that inhib-
itory antibodies to neurotrophins involved in outgrowth from EC 
cultures (34) were effective in abolishing Th2-mediated axonal 
outgrowth (Figure 9A).
To determine whether there is crosstalk between IL-4 and neu-
rotrophin signaling at the level of the AKT and MAPK pathways in 
neurons, we tested whether IL-4 pretreatment would potentiate this 
pathway in neurotrophin-treated neurons. Indeed, pretreatment 
with IL-4 elicited an increase in MAPK signaling in neurotroph-
in-treated cultures, as evidenced by an increase in phosphorylated 
MAPK44 to total MAPK44 (Figure 9, B and C). This effect was not 
present when Il4r–/– neurons were treated with IL-4 before neuro-
trophins were applied (Figure 9, B and D). Furthermore, blocking 
the AKT and MAPK signaling pathways downstream of IL-4R (35) 
and neurotrophin signaling (36) also abolished the Th2-induced 
outgrowth of axons in EC slice cultures (Figure 9E).
To determine whether IL-4 could be a relevant treatment for 
CNS injury, we examined whether the IL-4R is expressed in the 
relevant compartment of CNS neurons in vivo. As demonstrated 
in cultured neurons, expression of IL-4Rα was detectable on spi-
nal axons, including those of the corticospinal tract (Figure 9F and 
Supplemental Figure 5).
To determine whether the IL-4–induced axonal outgrowth 
and IL-4R expression in the corticospinal tract could be harnessed 
therapeutically, we injected Th2 cells directly into the site of a 
mild spinal cord injury, with PBS- and Th1-injected mice serv-
ing as controls, and assayed the mice for axonal outgrowth and 
functional recovery. The locally injected T cells survived in the 
spinal cord and could be seen even 5 mm caudal of the injection 
site (Supplemental Figure 6). Despite the fact that wild-type mice 
already display a highly Th2-skewed environment in the injured 
spinal cord (Figure 3A), addition of exogenous Th2-skewed cells, 
but not Th1-skewed cells, was able to further potentiate axonal 
outgrowth of corticospinal tract axons 5 mm distal to the injury 
site (Figure 9, G and H) and to promote a significant increase in 
functional recovery from spinal cord injury (Figure 9I).
Discussion
Our results demonstrate that neuroprotection (studied after 
optic nerve crush injury), axon regrowth, and functional recov-
ery (studied after spinal cord contusive injury), all benefit from 
an antigen-independent response of IL-4–producing T cells 
induced by local damage-associated molecules. Injured tissue, 
thus, induces a neuroprotective T cell response, which is MHCII 
independent and MyD88 dependent. IL-4–producing T cells 
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the connective tissue above the sclera. The venous sinus around the 
optic nerve was retracted to expose the optic nerve, and the nerve was 
crushed using an N5 self-closing forceps 2 mm behind the globe for 3 
seconds. The mice were then allowed to recover at 37°C on a warming 
pad before returning to their home cages.
Retina excision. Mice were enucleated, and the corneas removed 
at the corneal limbus. The lens and the underlying vitreous were 
removed with forceps. The retinas was separated from the sclera and 
pigment epithelium. Four cuts were made toward the optic disc, and 
the retina was mounted on nitrocellulose paper and fixed in 4% PFA 
overnight. Pictures of all 4 quadrants of the retina were taken at equal 
distances from the optic disc of the retina using an Olympus IX-71 
microscope. The pictures were then counted by a blinded observer to 
determine the number of RGCs per field.
Spinal cord injury. Mice were anesthetized with a 1:1:8 mixture 
of ketamine/xylazine/saline. A 15-mm midline skin incision was per-
formed over the T6-T13 vertebra, and the connective and muscle tis-
sues were bluntly dissected to expose the lamina. A laminectomy was 
performed using rongeurs at T9 to expose the dorsal spinal cord. The 
vertebral column was stabilized with angled clamps attached to the T7 
and T12 transverse processes. A calibrated contusion injury (mild or 
severe) of the spinal cord was induced by an Infinite Horizon Impactor 
(IH-0400 Impactor Precision Systems and Instrumentation; severe 
spinal cord injury) or with a modified SPI Correx Tension/Compres-
sion Gage (Penn Tool; mild spinal cord injury) at 10 cN for 3 seconds 
(42). After injury, the muscles and skin were sutured separately. Mice 
whose actual force varied by greater than 10% of the calibrated force 
were removed from analysis. The bladders of all mice were expressed 
twice a day and were tested for neurologic deficits using the Basso 
mouse scale for locomotion (18). The Basso mouse scale for locomo-
tion was performed by 2 independent investigators, both of whom 
were blind to the group identity.
Injection of labeled T cells after spinal cord injury. After MACS sepa-
ration, T cells were washed twice with PBS and were injected into the 
spinal cord lesion (1 × 105 cells in 1 μl per mouse) using a Hamilton 
micropipette. For tracing T cell migration in the spinal cord, T cells 
were incubated with 5 μM CFDA-SE (Molecular Probes, C1157) in PBS 
(1 × 107 cells/ml) for 5 minutes.
T cell adoptive transfer. Total lymphocytes were isolated from 
total lymph nodes of naive mice. The lymph nodes were passed 
through a 70-μm screen to obtain a single-cell suspension. The 
CD4+ T cell population was negatively enriched on autoMACS using 
the CD4+ T Cell Isolation Kit (Miltenyi Biotec) according to the 
manufacturer’s instructions, and 3 × 106 CD4+ T cells were injected 
i.v. into Rag1–/– recipients. The T cells were allowed to reconstitute 
for the indicated times before optic nerve injury was performed. 
Engraftment was confirmed by flow cytometry.
Bone marrow chimeras. C57BL/6 mice were subjected to split dose 
irradiation, receiving a 3.5-Gy dose to sensitize the mouse, followed 
24 hours later by a lethal 9.5-Gy dose. Two hours after the second 
dose of irradiation, the mice were injected i.v. with 107 bone marrow 
cells derived from the femurs and tibias of donor mice, as previously 
described. For head-covered irradiation, heads were covered with 
lead shields during both doses of irradiation. Briefly, femurs and tib-
ias were removed from mice, and muscles and tendons were cleaned 
from the bones. Both ends were cut off, and the marrow was flushed 
out using a 26-gauge needle with PBS containing 1% FBS. Red blood 
undergone rigorous double-blind randomized trials or have failed 
in these trials (39–41). Treatment with IL-4, therefore, is an espe-
cially promising target due to its ability to control both neuropro-
tection and functional regrowth in the injured CNS, where there 
are so few viable treatment options.
Methods
Animals. C57BL/6, Il4–/–, Rag1–/–, Myd88–/–, MHCII KO, C57BL/6-UbcGFP, 
and C57BL/6-β-actin-GFP strains of mice were purchased from The 
Jackson Laboratory; OTII/Rag1 –/– mice were purchased from Taconic. 
KN2 mice were a gift from M. Mohrs (The Trudeau Institute, Saranac 
Lake, New York, USA). B10.PL and BALB/c mice were purchased from 
Charles River. IL-4R mutant mice (Y500F) were a gift from Talal Cha-
tila (Washington University School of Medicine, St. Louis, Missouri, 
USA), Il4r–/– mice were a gift from Nancy Noben Trauth (NIH, Rockville, 
USA), Camk2g-Cre Il4rfl/fl mice were a gift from Frank Brombacher (Uni-
versity of Cape Town, Cape Town, South Africa), and Camk2g-Cre mice 
were a gift from Gunther Schütz (DKFZ, Heidelberg, Germany). All 
animals were housed in temperature- and humidity-controlled rooms, 
maintained on a 12-hour light/dark cycle (lights on 7:00 AM), and age 
matched in each experiment. All strains were kept in identical housing 
conditions. All procedures complied with regulations of the Institu-
tional Animal Care and Use Committee at University of Virginia or with 
German guidelines on the use of laboratory animals.
Retrograde labeling of RGCs. Mice were anesthetized, and the skull 
was exposed and immobilized in a stereotactic device. Holes were drilled 
in the skull above the superior colliculus (bilaterally 2.9 mm caudal to 
bregma and 0.5 mm lateral to midline). One μl 4% Fluoro-Gold was 
injected 2 mm below the meningeal surface at a rate of 0.5 μl/min using 
a Hamilton syringe and an automatic injector. The dye was allowed to 
diffuse into the tissue for 1 minute before the syringe was removed. The 
scalp was then sutured closed, and the mice were allowed to recover on 
warming pads at 37°C before being returned to their home cages.
Optic nerve injury. Mice were subjected to an optic nerve injury 3 
days after stereotactic surgery. Briefly, mice were anesthetized with 
a 1:1:8 mixture of ketamine/xylazine/saline. An incision was made in 
Figure 8. T cell–derived IL-4 acts on neurons to induce axonal regrowth. 
(A) Cortical ECs with outgrowing axons (A) oriented toward the T cells (T). 
Scale bar: 300 μm. (B) Culture of Th2 cells with cortical ECs (n = 29–33 per 
condition). (C) Coculture of wild-type slices with activated Th2 cells in the 
presence of neutralizing anti–IL-4 antibody (n = 22–25 per condition). (D) 
Coculture of wild-type slices with activated Th2 cells in the presence of 
neutralizing anti–IL-10 or anti–IL-13 antibodies (n > 12 per group). (E) Axon 
growth of slices derived from Il4r–/– mice in the presence or absence of Th2 
cells (n = 12–18 per condition). (F) Axon ingrowth coculture model of the 
entorhinal cortex and hippocampus in vitro (33). Entorhinal cortex (EnC) 
explants of mice, which express EGFP under control of the β-actin promoter 
with wild-type hippocampus (HC). The perforant path (PP) fibers originat-
ing from EGFP+ EC slices reinnervated the dentate gyrus (DG). CA, cornu 
ammonis. Scale bars: 300 μm (top); 15 μm (bottom left); 3 μm (bottom 
right). (G) Quantification of the EGFP+
 
area in the hippocampus in the 
presence of recombinant IL-4 (500 ng/ml) (n = 14–15 per condition). (H) qRT-
PCR of primary neurons and Th2 cells. NTC, no template control. (I) IL-4Rα 
immunofluorescent staining of cultured neurons. Scale bar: 10 μm. (J) Axon 
density from slices obtained from Camk2g-Cre Il4rfl/fl mice incubated with 
Th2 cells (n = 28–32 per condition). (B–E, H, and J) *P < 0.05, **P < 0.01, 
1-way ANOVA with Bonferroni’s post-test. (G) *P < 0.05, 2-tailed Student’s 
t test. Error bars represent SEM.
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T cell skewing assay. Total lymph nodes were removed from mice, 
and a single-cell suspension was made by passing the cells through a 
70-μm strainer. CD4+ and CD4– lymphocyte fractions were isolated 
on autoMACS using magnetic bead separation (Miltenyi Biotec) 
and incubated in a 2:1 ratio (2 × 106 CD4– cells/ml to 1 × 106 CD4+ 
cells/ml) in the presence or absence of 3 optic nerves/ml in T cell cul-
ture media, consisting of RPMI supplemented with 10% FCS, 10 mM 
HEPES, NEAA, Na-pyruvate, 50 mM 2-mercaptoethanol, l-gluta-
mine, and Penicillin-Streptomycin (Invitrogen). Optic nerves were 
obtained from either naive uninjured mice or from mice injured 3 
days prior to excision. It is clearly stated in the text for each experi-
ment whether the optic nerve was obtained from injured or uninjured 
donors. In Transwell experiments, nerves were put on top of a 0.4-μm 
Transwell insert, and in the T cell–only experiments, the CD4– frac-
tion was omitted. After 72 hours of culture, CD4+ T cells were isolated 
from total lymph nodes using the CD4+ T Cell Isolation Kit (Miltenyi) 
according to the manufacturer’s instructions. Cells were cultured at 
5 × 105 cell/ml in RPMI containing 50 μM 2-mercaptoethanol, 100 
U/ml IL-2, 10% FBS, 1 μg/ml anti-CD28, NEAA, 10 mM HEPES, 
sodium pyruvate, and l-glutamate on plates that had been coated 
with 1 μg/ml anti-CD3 antibody. After 3 days, the cells were moved to 
a new plate, and the media was supplemented with fresh media lack-
ing anti-CD28 or cytokines. Two days later, the cells were incubated 
with 10 ng/ml brefeldin A and stimulated with PMA/ionomycin for 5 
hours before analysis by flow cytometry. Cells were then stained for 
extracellular markers, fixed in IC fixation buffer (eBioscience), and 
stained for intracellular markers in 0.3% saponin.
Primary neuronal cultures. Primary neuronal cells were prepared 
from E15 BALB/c mouse cortices by enzymatic dissociation using 
0.5% trypsin and DNase treatment (0.1 mg/ml) in HBSS, followed by 
mechanical dissociation by trituration to obtain a single-cell suspen-
sion. Cells were seeded on poly-d-lysine–coated cell culture plates 
directly (96-well plate) or on coated coverslips placed inside the wells 
of a 24-well plate and cultured at 37°C and 5% CO2 in Neurobasal 
medium containing 2% B-27, 1% l-glutamine, and 1% penicillin/
streptomycin for 2 hours prior to the start of the experiments. All cell 
culture reagents were from Gibco (Invitrogen). Neurite length from 
single neuronal cells was analyzed using ImageJ analysis software 
(NIH) as described previously (44). The length of the longest neurite 
of 50 single neurons per condition was measured using the following 
criteria. Neurites innervating other neurons and neurites running out 
of the picture were excluded from the data, and the length should be 
longer than the diameter of the cell body. The mean neurite length per 
condition was determined, and data were expressed as mean ± SEM. 
Experiments were repeated 4 times (n = 4).
Western blot. Cells were grown for 6 days in neuronal medium, and 
IL-4 (10 ng/ml) was added 2 hours before the addition of NT-3 (10 ng/ml, 
Peprotech Inc.) for 5 minutes. Cells were lysed, and protein concen-
trations were determined by the BCA protein assay (Pierce). Ten μg 
of each sample were electrophoresed on 10 % SDS-PAGE and electro-
transferred to PVDF membranes, which were blocked with 2 % BSA in 
TBST for 1 hour at room temperature. Primary anti–phospho-MAPK 
p42/44 antibodies (1:250, Cell Signaling) were incubated overnight at 
4°C. The HRP-linked secondary antibodies were incubated for 1 hour at 
room temperature (1:5,000), and signals were detected using the ECL 
Plus System (all Amersham Pharmacia). Membranes were stripped and 
Western blotting was performed as described above with primary anti-
cells were lysed using ACK lysis buffer, and live cells were counted and 
resuspended at 108 cells/ml. The bone marrow was allowed to engraft 
for at least 4 weeks before the mice were used for experiments.
Thymus implantation. This procedure was performed as previ-
ously described (43). Briefly, thymi were removed from P5 donor pups. 
Three-week-old mice were anesthetized with a 1:1:8 mixture of ket-
amine/xylazine/saline. A 15-mm incision was made on skin and peri-
toneum at the right flank of the recipient mouse, and the kidney was 
exposed. A scalpel was used to scratch the kidney capsule, and the thy-
mus was implanted below the capsule. The kidney was then returned 
to the peritoneum, and the peritoneum and skin were sutured closed. 
The mice were allowed to recover at 37°C on a heating pad before 
returning to their cages. T cell engraftment was allowed to take place 
for at least 6 weeks prior to any further manipulation.
In vivo brefeldin A treatment. Two weeks after spinal cord injury, 
mice were injected i.v. with 300 μg brefeldin A. Five hours after injec-
tion, mice were sacrificed, and spinal cords were dissociated with 
papain and prepared for flow cytometry as described below.
Flow cytometry. For flow cytometric analysis of lymph nodes, the 
lymph nodes were isolated and passed through a 70-μm strainer in PBS 
containing 1% BSA and 2 mM EDTA to obtain a single-cell suspen-
sion. For flow cytometric analysis of spinal cords, the spinal cords were 
removed from mice, and the spinal meninges were removed from spi-
nal cords. The spinal cords were minced and then were dissociated for 
45 minutes at 37°C in 4 U/ml papain (Worthington Biochemical) with 
0.004% DNase added (Sigma-Aldrich). The spinal cords were then 
triturated to form a single-cell suspension. The cells were spun down 
and resuspended in 50 μl unlabeled anti-CD16/32 in FACS buffer for 
20 minutes at 4°C, and then 50 μl antibody staining cocktail was added 
for 30 minutes at 4°C, after which the cells were washed and analyzed. 
The following antibodies were used and are all from eBioscience: 
CD4-PerCp Cy5.5, TCRβ-APC eFluor780, hCD2-APC, CD45-APC, 
CD8- eFluor 450, CD19-PE, B220-PE, IL-4–PE, and IFN-γ–APC. The 
samples were run on cytometers at the UVA Flow Core.
Figure 9. T cell–derived IL-4 potentiates neurotrophin signaling to 
induce axonal regrowth. (A) Combined inhibition of NT-3/NT-4/NGF in 
cortical cocultures (n = 25–27 per condition). (B) Representative blots 
and quantification of phosphorylated MAPK44 (pMAPK44) and total 
MAPK44 (tMAPK44) in (C) wild-type and (D) Il4r–/– neuronal cultures that 
have been treated with IL-4 and/ or NT-3 (n = 11, wild-type; n = 9, Il4r–/–). 
(E) Inhibition of the MAPK or AKT in cortical cocultures (n = 8–33). (F) 
Immunofluorescence of IL-4R in wild-type spinal cords and IL-4R KO 
animals. Higher magnification of the IL-4R–positive structures displayed 
tubular structures indicating a delineation of the axonal membrane 
(third panel in top row) and no signal in Il4r–/– (fourth panel in top row). 
Immunofluorescence in sections cut along the longitudinal axis of the 
spinal cord and its long-range axon tracts revealed IL-4R (green signal) 
located on NCAM-positive membranes (purple signal) of SMI 312-positive 
axons (red signal; bottom row). Dotted lines indicate axonal membranes. 
Scale bars: 50 μm (first and second panels, top row); 10 μm (third and 
fourth panels, top row); 1 μm (bottom row). CST, corticospinal tract. (G) 
Schematic drawing of the injection of Th2 cells after spinal cord injury, 
with representative photomicrographs. Scale bar: 20 μm. (H) Axonal 
sprouting/regrowth in spinal cord–injured mice injected with Th1 or Th2 
T cells (n = 8–10 per condition). (I) Locomotion analysis after spinal cord 
injury by after intralesion injections of skewed CD4+ cells (n = 20, PBS;  
n = 9, Th2; n = 8 Th1). (A, C–E, and H) *P < 0.05, ***P < 0.001, 1-way 
ANOVA with Bonferroni’s post-test. (I) **P < 0.01, repeated-measures 
2-way ANOVA. Error bars represent SEM.
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on a glass slide and each slice was placed directly next to the explants 
derived from mice of the same strain in a collagen matrix (1.2 × 105 cells 
per drop, 1 drop = 30 μl collagen). Consecutive covering of the T cell 
drop and the explant with another drop of collagen (30 μl) ensured a 
standardized distance from the edge of the T cell drop. The sterile cul-
tivation medium contained 25% HBSS, 25% heat-inactivated normal 
horse serum, 8 g/l MEM HEPES, 4 mM l-glutamine, 4 mg/l insulin, 
0.58% bicarbonate solution (Gibco), 1.2% Glucose-20 (Braun), 1% 
penicillin-streptomycin solution (×100), 0.8 mg/l vitamin C, and 5 
mM Trisbase (Sigma-Aldrich) at pH 7.35. The collagen cocultures were 
incubated at 37°C in a humidified atmosphere with 5% CO2. After 48 
hours in vitro, the collagen cocultures were analyzed microscopically.
Cocultures of EC and hippocampal slices derived from β-actin-
 GFP mice (EC) and wild-type mice (hippocampus) were obtained and 
prepared as described elsewhere (33). Recombinant IL-4 was directly 
applied to the culture medium.
Measurement of axonal growth from cortical slices. To evaluate axonal 
outgrowth from the explants, we used a highly reliable evaluation proce-
dure described previously (45), using image analysis software (ImageJ) 
to quantify axonal density after 2 days in culture. Neurite outgrowth was 
photodocumented at a total magnification of ×100, using a ×10 Olympus 
LCPLANFL objective (Olympus IX70). To determine axonal density, 
image processing was based on the Sobel algorithm, which performs a 2D 
spatial gradient measurement in a microphotograph and so emphasizes 
regions of high spatial density that correspond to axons in the area investi-
gated. To determine the axonal density, the mean intensity was calculated 
in a standardized area in a microphotograph of every single cortical slice. 
Values were normalized to the mean of the control (= 100%).
Inhibitors. The following blocking antibodies were mixed into 
the collagen and compared with the corresponding control anti-
bodies in the same concentration: rabbit anti-mouse NGF (2 μg/ml, 
IBT), rabbit anti–NT-4 (25 μg/ml, Millipore), chicken anti-human 
NT-3 (25 μg/ml, Promega), chicken IgY (25 μg/ml, Promega), and 
rabbit IgG (27 μg/ml, Sigma-Aldrich).
bodies of the nonphosphorylated protein forms (1:250, Cell Signaling) 
and HRP-linked anti-rabbit antibody (1:5,000). Analysis was performed 
with Alpha Imager or ImageJ software. Values were calculated as the 
percentage of phosphorylated protein to total protein. Values were nor-
malized to NT-3 (=100%).
qRT-PCR. RNA was isolated with the Bioline Isolate RNA Kit, 
according to the manufacturer’s instructions. cDNA was synthesized 
using the Applied Biosystems High-Capacity Reverse Transcription 
Kit according to the manufacturer’s instructions, and the resulting 
cDNA was analyzed on a CFX384 qPCR system from Bio-Rad using 
a TaqMan primer for Gata3, with Gapdh as an internal loading control 
(Applied Biosystems).
Generation of ConA-activated T cells. Briefly, we prepared cultures 
of mixed lymphocytes from spleens and lymph nodes (4 × 106 cells/
ml) and stimulated them with 1 μg/ml ConA. To generate Th1 T cells, 
we added 1–50 ng/ml recombinant mouse IL-12 (R & D Systems) and 
1 μg/ml anti-mouse IL-4 (clone 11B11, BD Pharmingen). To generate 
Th2 cells, 4 ng/ml recombinant mouse IL-4 (BD Pharmingen) and 
1 μg/ml anti-mouse IL-12 (BD Pharmingen) were added. Between days 
7 and 9, the T cells were restimulated with ConA, using irradiated sple-
nocytes and thymocytes functioning as antigen-presenting cells. This 
was carried out in the presence of IL-12 and anti–IL-4 for the expansion 
of Th1 cells or IL-4 and anti–IL-12 for the expansion of Th2 cells. After 
restimulation, CD4+ T cells were prepared by MACS (Miltenyi Biotec).
Cocultures of organotypic cortex explants and T helper cells and EC 
with hippocampal slices. Briefly, collagen type I from rat tail (Sigma- 
Aldrich) was dissolved in 0.1 M acetic acid at a final concentration of 
2 mg/ml. Of the collagen solution, 1 ml was mixed with 50 μl DMEM 
medium (Gibco) and neutralized (pH 7.4) with reconstitution buffer 
(2.2% sodium bicarbonate in 0.8 M NaOH solution). Organotypic slice 
cultures were prepared as follows. Briefly, the entorhinal cortex was 
dissected from P2–P3 murine brains and cut into 350-μm-thick slices 
using a tissue chopper (Technical Products International). Collagen 
drops (30 μl) containing homogenously distributed T cells were placed 
Figure 10. Schematic representation 
of the proposed molecular events 
within the injured CNS. (a) Injury to 
the CNS results in (b) in T cell recruit-
ment to the site of injury and in induc-
tion of damage-associated molecular 
mediators. (c) Damage-associated 
molecular mediators released from 
the injured CNS signal on T cells to 
induce IL-4 expression in MyD88-de-
pendent manner. (d) T cell–derived 
IL-4 signals through neuronal IL-4R to 
(e) potentiate neurotrophin signaling 
and increase neuronal survival.
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